TrialRespiratory research2021

Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial.

Jinping Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.